Grant Awards in April 2003

Preface >>
Facts and Figures >>

Principal Investigator Project Title/Link
Dr. David Briscoe
Harvard Medical School, Boston, USA
Vascular Endothelial Growth Factor in Acute and Chronic Rejection
Dr. Ginny Bumgardner
Ohio State University, Columbus, USA
Analysis of a Novel Strategy which Suppresses Aggressive (CD4-Independent) CD8+ T-Cell-Initiated Hepatocyte Rejection
Dr. Juan Contreras
University of Alabama, Birmingham, USA
Increase of Islet Engraftment by Mobilizing Bone-Marrow-Derived Endothelial Progenitor Cells
Prof. Philip Halloran
University of Alberta, Edmonton, Canada
Mechanisms of Renal Allograft Rejection
Prof. John Kirby
University of Newcastle, Newcastle upon Tyne, UK
Therapeutic Elimination of Intraepithelial T Cells: A Strategy to Reduce Epithelial-Mesenchymal Transdifferentiation and Chronic Allograft Dysfunction
Dr. Wei-Ping Min
University of Western Ontario, London, Canada
Novel Strategy for Inducing Transplant Tolerance by Genetically Modifying Dendritic Cells with siRNA
Dr. Jeffrey Schechner
Yale University School of Medicine, New Haven, USA
Vascularization of Engineered Human Skin Equivalents
Prof. Ann Simpson
University of Technology, Sydney, Australia
Correction of Diabetes Using Insulin-Secreting Liver Cells
Dr. Peter Terness
University of Heidelberg, Heidelberg, Germany
Using the Immunosuppressive IDO Gene for Prevention of Allograft Rejection